Teva, Celltrion Gain FDA Approval for Generic Blood Cancer Bio-Drug | Ctech
Teva, Celltrion launch their Rituxan biosimilar Truxima | Drug Store News
Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States | Business Wire
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership | World Pharma Today
Teva teams up on biosims with Celltrion three years after its Lonza JV divorce | Fierce Biotech
Teva & Celltrion, Amgen & Allergan submit Herceptin biosimilars to FDA
Teva and Celltrion Launch Rituximab Biosimilar in US - Big Molecule Watch
Celltrion, Teva announce FDA approval of HERZUMA
Celltrion signs $160m drug license deal with Teva for North America - Nikkei Asia
Truxima Hits 20% Share For Teva :: Generics Bulletin
Jobs with Celltrion Healthcare (Formerly Known As Celltrion) | page 2
Teva teams with Celltrion in $160m biosimilar deal - Globes
Drama in Teva: Cutting 7,000 jobs in 45 countries ; share price plunges
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Celltrion and Teva Snag Second Biosimilar Approval of a Genentech Drug | BioSpace
Teva: Migraine Mab Delay After 'Negative Surprise' of Celltrion Warning - BioProcess InternationalBioProcess International
Teva two: FDA approves Celltrion-made Herceptin biosimilar - BioProcess InternationalBioProcess International
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Teva buys US rights to Celltrion biosimilars -
Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan® (ri
Teva, Celltrion get FDA nod for biosimilar to Roche's breast cancer drug
And Then There Were None: Celltrion Signs AbbVie Licensing Deal for Its Adalimumab Biosimilar CT-P17
Teva, Celltrion win FDA approval for Rituxan biosimilar - Globes
Teva bolsters its biosimilar business through $160m Celltrion deal
Teva and Celltrion Launch Trastuzumab Biosimilar in U.S. - Big Molecule Watch
Celltrion's Truxima gets sales approval in US
Teva and Celltrion Launch Truxima (biosimilar- rituximab) to Treat Wegener's Granulomatosis and Microscopic Polyangiitis in the US
